JU KIM: Open Payments
NPI 1710764550 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 55 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $546 · 2025 $1,076
Food & beverage: $1,076
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $214 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $190 |
| Merck Sharp & Dohme LLC | 6 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
| BridgeBio Pharma, Inc. | 6 | $88 |
| Amgen Inc. | 5 | $82 |
| Edwards Lifesciences Corporation | 2 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $58 |
| SCPHARMACEUTICALS INC. | 2 | $37 |
| PFIZER INC. | 2 | $32 |
Products named: LEQVIO, JARDIANCE, VERQUVO, Kerendia, Attruby, REPATHA, FARXIGA, FUROSCIX.
Industry payments across NY — which companies pay providers there.
